Association of arterial stiffness with serum bilirubin levels in established coronary artery disease

Internal Medicine

Volumn 51, Issue 16, 2012, Pages 2083-2089

  Zhu, Cansheng ^a   Xiong, Zhaojun ^a   Zheng, Zhenda ^a   Chen, Yanming ^a   Chen, Xiaohong ^a   Qian, Xiaoxian ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Antioxidant; Arterial stiffness; Brachialankle pulse wave velocity; Coronary artery disease; Total bilirubin

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTERIAL STIFFNESS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHOLINESTERASE BLOOD LEVEL; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PULSE WAVE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ANKLE BRACHIAL INDEX; BILIRUBIN; CORONARY ARTERY DISEASE; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; VASCULAR STIFFNESS;

EID: 84865134092     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.7701     Document Type: Article

References (45)

1. O'Rourke MF, Franklin SS. Arterial stiffness: reflections on the arterial pulse. Eur Heart J 27: 2497-2498, 2006.
2. Dart AM, Kingwell BA. Pulse pressure: a review of mechanisms and clinical relevance. J Am Coll Cardiol 37: 975-984, 2001.
3. Matsui Y, Kario K, Ishikawa J, Eguchi K, Hoshide S, Shimada K. Reproducibility of arterial stiffness indices (pulse wave velocity and augmentation index) simultaneously assessed by automated pulsewave analysis and their associated risk factors in essential hypertensive patients. Hypertens Res 27: 851-857, 2004.
4. Yamashina A, Tomiyama H, Takeda K, et al. Validity, reproducibility, and clinical significance of noninvasive brachialankle pulse wave velocity measurement. Hypertens Res 25: 359-364, 2002.
5. Satoh H, Kishi R, Tsutsui H. Metabolic syndrome is a significant and independent risk factor for increased arterial stiffness in Japa- nese subjects. Hypertens Res 32: 1067-1071, 2009.
6. Tomiyama H, Tanaka H, Hashimoto H, et al. Arterial stiffness and concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 40: 18-23, 1994.
7. Xu L, Jiang CQ, Lam TH, et al. Brachialankle pulse wave velocity and cardiovascular risk factors in the non-diabetic and newly diagnosed diabetic Chinese: Guangzhou Biobank Cohort Study- CVD. Diabetes Metab Res Rev 26: 133-139, 2010.
8. Llesuy SF, Tomaro ML. Heme oxygenase and oxidative stress. Evidence of involvement of bilirubin as physiological protector against oxidative damage. Biochim Biophys Acta 1223: 9-14, 1994.
9. Sedlak TW, Saleh M, Higginson DS, Paul BD, Juluri KR, Snyder SH. Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. Proc Natl Acad Sci USA 106: 5171-5176, 2009.
10. Vitek L, Jirsa M, Brodanova M, et al. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 160: 449-456, 2002.
11. Morita T. Hemeoxygenase and atherosclerosis. Arterioscler Thromb Vasc Biol 25: 1786-1795, 2005.
12. Neuzil J, Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem 269: 16712-16719, 1994.
13. Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 40: 18-23, 1994.
14. Kawamura K, Ishikawa K, Wada Y, et al. Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction. Arterioscler Thromb Vasc Biol 25: 155-160, 2005.
15. Vitek L, Schwertner HA. The heme catabolic pathway and its protective effects on oxidative stressmediated diseases. Adv Clin Chem 43: 1-57, 2007.
16. Mazzone GL, Rigato I, Ostrow JD, et al. Bilirubin inhibits the TNFα-related induction of three endothelial adhesion molecules. Biochem Biophys Res Commun 386: 338-344, 2009.
17. Vlachopoulos C, Dima I, Aznaouridis K, et al. Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation 112: 2193-2200, 2005.
18. Mäki-Petäjä KM, Hall FC, Booth AD, et al. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation 114: 1185-1192, 2006.
19. Roman MJ, Devereux RB, Schwartz JE, et al. Arterial stiffness in chronic inflammatory diseases. Hypertension 46: 194-199, 2005.
20. Mahmud A, Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension 46: 1118-1122, 2005.
21. Amar J, Ruidavets JB, Peyrieux JC, et al. C-reactive protein elevation predicts pulse pressure reduction in hypertensive subjects. Hypertension 46: 151-155, 2005.
22. Kimm H, Yun JE, Jo J, Jee SH. Low serum bilirubin level as an independent predictor of stroke incidence: a prospective study in Korean men and women. Stroke 40: 3422-3427, 2009.
23. Allen LA, Felker GM, Pocock S, et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in HEART Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail 11: 170-177, 2009.
24. Takeda Y, Takeda Y, Tomimoto S, Tani T, Narita H, Kimura G. Bilirubin as a prognostic marker in patients with pulmonary arterial hypertension. BMC Pulm Med 10: 22, 2010.
25. Molvarec A, Rigó J Jr, Lázár L, et al. Increased serum heat-shock protein 70 levels reflect systemic inflammation, oxidative stress and hepatocellular injury in preeclampsia. Cell Stress Chaperones 14: 151-159, 2009.
26. Bulmer AC, Blanchfield JT, Toth I, Fassett RG, Coombes JS. Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection. Atherosclerosis 199: 390-396, 2008.
27. Vítek L, Novotný L, Sperl M, Holaj R, Spácil J. The inverse association of elevated serum bilirubin levels with subclinical carotid atherosclerosis. Cerebrovasc Dis 21: 408-414, 2006.
28. Erdogan D, Gullu H, Yildirim E, et al. Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis 184: 431-437, 2006.
29. Novotný L, Vítek L. Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med (Maywood) 288: 568-571, 2003.
30. Perlstein TS, Pande RL, Creager MA, Weuve J, Beckman JA. Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999-2004. Am J Med 121: 781-788, 2008.
31. Wu TW, Fung KP, Wu J, Yang CC, Weisel RD. Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem Pharmacol 51: 859-862, 1996.
32. Crawford RS, Kirk EA, Rosenfeld ME, LeBoeuf RC, Chait A. Dietary antioxidants inhibit development of fatty streak lesions in the LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol 18: 1506-1513, 1998.
33. Azen SP, Qian D, Mack WJ, et al. Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering. Circulation 94: 2369-2372, 1996.
34. Ryan TJ, Bauman WB, Kennedy JW, et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). Circulation 88: 2987-3007, 1993.
35. Huang SS, Huang PH, Leu HB, Wu TC, Lin SJ, Chen JW. Serum bilirubin predicts long-term clinical outcomes in patients with cardiac syndrome X. Heart 96: 1227-1232, 2010.
36. Pae HO, Son Y, Kim NH, Jeong HJ, Chang KC, Chung HT. Role of heme oxygenase in preserving vascular bioactive NO. Nitric Oxide 23: 251-257, 2010.
37. Sugawara J, Hayashi K, Yokoi T, et al. Brachialankle pulse wave velocity: an index of central arterial stiffness? J Hum Hypertens 19: 401-406, 2005.
38. Lin WY, Lai MM, Li CI, et al. In addition to insulin resistance and obesity, brachialankle pulse wave velocity is strongly associated with metabolic syndrome in Chinese: a population-based study (Taichung Community Health Study, TCHS). J Atheroscler Thromb 16: 105-112, 2009.
39. Tomiyama H, Koji Y, Yambe M, et al. Brachial: ankle pulse wave velocity is a simple and independent predictor of prognosis in patients with acute coronary syndrome. Circ J 69: 815-822, 2005.
40. Yambe M, Tomiyama H, Hirayama Y, et al. Arterial stiffening as a possible risk factor for both atherosclerosis and diastolic heart failure. Hypertens Res 27: 625-631, 2004.
41. Okamoto T, Masuhara M, Ikuta K. Combined aerobic and resistance training and vascular function: effect of aerobic exercise before and after resistance training. J Appl Physiol 103: 1655-1661, 2007.
42. Ochi M, Kohara K, Tabara Y, et al. Arterial stiffness is associated with low thigh muscle mass in middle-aged to elderly men. Atherosclerosis 212: 327-332, 2010.
43. Miura S, Tanaka E, Mori A, et al. Hormone replacement therapy improves arterial stiffness in normotensive postmenopausal women. Maturitas 45: 293-298, 2003.
44. Perrot-Applanat M, Groyer-Picard MT, Garcia E, Lorenzo F, Milgrom E. Immunocytochemical demonstration of estrogen and progesterone receptors in muscle cells of uterine arteries in rabbits and humans. Endocrinology 123: 1511-1519, 1988.
45. Fujimoto R, Morimoto I, Morita E, Sugimoto H, Ito Y, Eto S. Androgen receptors, 5 alpha-reductase activity and androgendeBiochem. Mol Biol 50: 169-174, 1994.